Annexon, Inc.
US ˙ NasdaqGS ˙ US03589W1027

Introduzione

Questa pagina fornisce un'analisi completa dello storico delle operazioni di insider trading note di Jung Choi. Gli insider sono funzionari, direttori o investitori importanti di una società. In generale, è illegale per gli insider effettuare operazioni di compravendita nelle loro aziende sulla base di informazioni materiali non pubbliche. Ciò non significa che sia illegale per loro effettuare qualsiasi operazioni di trading nelle proprie aziende. Tuttavia, devono segnalare tutte le operazioni alla SEC tramite un modulo 4. Nonostante queste restrizioni, la ricerca accademica suggerisce che gli insider, in generale, tendono a sovraperformare il mercato nelle proprie società.

Redditività media delle transazioni

La redditività media delle transazioni è il rendimento medio di tutti gli acquisti effettuati sul mercato aperto dagli insider negli ultimi tre anni. Pe calcolarla, esaminiamo tutti gli acquisti non pianificati effettuati dall'insider sul mercato aperto, escludendo tutte le operazioni che sono state parte di un piano di trading 10b5-1. Calcoliamo quindi la performance media di queste operazioni nell'arco di 3, 6 e 12 mesi e facciamo la media di ciascuna di queste durate per generare un indicatore di performance finale per ogni operazione. Infine, facciamo la media di tutti gli indicatori di performance per calcolare un indicatore di performance per l'insider. Questo elenco comprende solo gli insider che hanno effettuato almeno tre operazioni negli ultimi due anni.

Se la redditività delle operazioni di questo insider è "N/D", l'insider non ha effettuato acquisti sul mercato aperto negli ultimi tre anni, oppure le operazioni effettuate sono troppo recenti per poter calcolare un indicatore di performance affidabile.

Frequenza di aggiornamento: giornaliera

Vedi l'elenco degli insider trader più redditizi

Società con posizioni di insider dichiarate

I depositi SEC indicano che Jung Choi ha dichiarato partecipazioni o transazioni nelle seguenti società:

Titolo Ruolo Ultime partecipazioni dichiarate
US:ANNX / Annexon, Inc. Director 33.000
US:GBT / Global Blood Therapeutics Inc. See Remarks 0
Come interpretare i grafici

I grafici seguenti mostrano l'andamento dei titoli dopo ogni operazione di mercato aperto non pianificata effettuata da Jung Choi. Per operazioni non pianificate si intendono operazioni non effettuate nell'ambito di un piano di trading 10b5-1. La performance dei titoli è rappresentata come variazione percentuale cumulativa del prezzo delle azioni. Ad esempio, se un'operazione di insider è stata effettuata il 1° gennaio 2019, il grafico mostrerà la variazione percentuale giornaliera del titolo fino ad oggi. Se il prezzo dell'azione passasse da 10 a 15 dollari durante questo periodo, la variazione percentuale cumulativa del prezzo dell'azione sarebbe del 50%. Una variazione di prezzo da 10 a 20 dollari sarebbe del 100%, mentre una variazione di prezzo da 10 a 5 dollari sarebbe del -50%.

In definitiva, cerchiamo di determinare la correlazione tra le operazioni dell'insider e i rendimenti in eccesso (positivi o negativi) del prezzo dell'azione, al fine di capire se l'insider sta programmando le proprie operazioni per trarre profitto da informazioni privilegiate. Immaginiamo che un insider stia facendo questo. In questa situazione, ci aspetteremmo (a) rendimenti positivi dopo gli acquisti, oppure (b) rendimenti negativi dopo le vendite. Nel caso (a), il grafico ACQUISTO mostrerebbe una serie di curve ascendenti, indicando rendimenti positivi dopo ogni operazione di acquisto. Nel caso (b), il grafico VENDITA mostrerebbe una serie di curve inclinate verso il basso, indicando rendimenti negativi dopo ogni operazione di vendita.

Tuttavia, questo non è sufficiente per trarre conclusioni. Se, ad esempio, il prezzo delle azioni della società è aumentato in maniera non ciclica per molti anni, allora ci aspetteremmo che tutti i grafici post-acquisto abbiano una pendenza rivolta verso l'alto. Allo stesso modo, ribassi non ciclici per molti anni darebbero luogo a grafici post-negoziazione rivolti verso il basso. Nessuno di questi grafici suggerisce un'attività di insider trading.

L'indicatore più forte sarebbe una situazione in cui il prezzo delle azioni fosse estremamente ciclico e vi fossero segnali positivi nel grafico ACQUISTO e curve negative nel grafico VENDITA. Questa situazione suggerirebbe che l'insider sta programmando le operazioni di trading per trarne un vantaggio finanziario.

Acquisti di insider ANNX / Annexon, Inc. - Analisi degli utili a breve termine

In questa sezione analizziamo la redditività di ogni acquisto non pianificato di insider sul mercato aperto effettuato in ANNX / Annexon, Inc.. Questa analisi aiuta a capire se l'insider genera costantemente rendimenti anomali e se vale la pena seguirlo. L'analisi riguarda l'anno successivo a ciascuna operazione, e i risultati sono teorici.

La tabella seguente mostra gli acquisti più recenti sul mercato aperto che non facevano parte di un piano di trading automatico.

Data dell'operazione Ticker Insider Azioni
dichiarate
Prezzo
dichiarato
Azioni
rettificate
Prezzo
rettificato
Base di costo Giorni fino al
massimo
Prezzo al
massimo
Profitto
massimo ($)
Rendimento massimo (%)
2025-12-01 ANNX Choi Jung 33.000 4,1900 33.000 4,1900 138.270 52 6.9600 91.410 66,11

Il prezzo rettificato è il prezzo rettificato per il frazionamento azionario. Leazioni rettificate sono le azioni rettificate per il frazionamento azionario.

ANNX / Annexon, Inc. Insider Trades
Vendite di insider ANNX / Annexon, Inc. - Analisi delle perdite a breve termine

In questa sezione, analizziamo l'evitamento delle perdite a breve termine di ogni vendita di insider non pianificata ed effettuata sul mercato aperto in ANNX / Annexon, Inc.. Un modello coerente di evitamento delle perdite può suggerire che future transazioni di vendita potrebbero predire cali di prezzo. L'analisi riguarda l'anno successivo a ciascuna operazione, e i risultati sono teorici.

La tabella seguente mostra le vendite più recenti sul mercato aperto che non facevano parte di un piano di trading automatico.

Data dell'operazione Ticker Insider Azioni
dichiarate
Prezzo
dichiarato
Azioni
rettificate
Prezzo
rettificato
Base di costo Giorni fino al
minimo
Prezzo al
minimo
Perdita massima
evitata ($)
Perdita massima
evitata (%)
Non sono note operazioni di mercato aperto non pianificate per questa combinazione di insider e titoli.

Il prezzo rettificato è il prezzo rettificato per il frazionamento azionario. Leazioni rettificate sono le azioni rettificate per il frazionamento azionario.

ANNX / Annexon, Inc. Insider Trades
Storico delle operazioni degli insider

Questa tabella mostra l'elenco completo delle operazioni effettuate da Jung Choi come comunicato alla Securities Exchange Commission (SEC).

Data di deposito Data della transazione Modulo Ticker Titolo Codice 10b5-1 Azioni Azioni rimanenti Variazione
percentuale
Prezzo
dell'azione
Valore
della transazione
Valore
rimanente
2025-12-03 2025-12-01 4 ANNX Annexon, Inc.
Common Stock
P - Purchase 33.000 33.000 4,19 138.270 138.270
2022-10-06 2022-10-05 4 GBT Global Blood Therapeutics, Inc.
Common Stock
D - Sale to Issuer -25.000 0 -100,00
2022-10-06 2022-10-05 4 GBT Global Blood Therapeutics, Inc.
Common Stock
D - Sale to Issuer -226.672 0 -100,00
2022-09-29 2022-09-29 4 GBT Global Blood Therapeutics, Inc.
Common Stock
G - Gift -73.855 226.672 -24,58
2022-09-29 2022-09-27 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2.674 300.527 0,90 3,40 9.092 1.021.792
2022-09-29 2022-09-27 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2.674 300.527 0,90 3,40 9.092 1.021.792
2022-09-29 2022-09-27 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 74.964 295.179 34,04 3,40 254.878 1.003.609
2022-09-29 2022-09-27 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2.275 220.215 1,04 65,82 149.740 14.494.551
2022-09-29 2022-09-27 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 16.902 217.940 8,41 16,40 277.193 3.574.216
2022-09-06 2022-09-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -1.861 201.038 -0,92 68,15 -126.827 13.700.740
2022-09-06 2022-09-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2.208 202.899 1,10
2022-09-06 2022-09-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2.763 200.691 1,40
2022-08-03 2022-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -2.126 197.928 -1,06 32,40 -68.882 6.412.867
2022-08-03 2022-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 6.145 200.054 3,17
2022-03-03 2022-03-01 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to buy)
A - Award 28.628 28.628
2022-03-03 2022-03-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 17.668 17.668
2022-03-03 2022-03-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 17.668 17.668
2022-03-03 2022-03-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2.763 16.577 -14,29
2022-03-03 2022-03-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -956 191.374 -0,50 29,87 -28.556 5.716.341
2022-03-03 2022-03-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2.763 192.330 1,46
2022-02-03 2022-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3.020 12.080 -20,00
2022-02-03 2022-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3.125 6.250 -33,33
2022-02-03 2022-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2.875 0 -100,00
2022-02-03 2022-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -3.340 189.567 -1,73 29,33 -97.962 5.560.000
2022-02-03 2022-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 9.020 192.907 4,91
2021-09-24 2021-08-01 4/A GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3.020 15.100 -16,67
2021-09-24 2021-08-01 4/A GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3.125 9.375 -25,00
2021-09-24 2021-08-01 4/A GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2.875 2.875 -50,00
2021-09-24 2021-08-01 4/A GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -3.743 182.367 -2,01 27,33 -102.296 4.984.090
2021-09-24 2021-08-01 4/A GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 9.020 186.110 5,09
2021-09-03 2021-09-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2.762 19.340 -12,50
2021-09-03 2021-09-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -1.370 183.887 -0,74 29,85 -40.894 5.489.027
2021-09-03 2021-09-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2.762 185.257 1,51
2021-09-03 2021-08-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 128 182.495 0,07 24,39 3.122 4.451.053
2021-08-03 2021-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3.020 15.100 -16,67
2021-08-03 2021-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3.125 9.375 -25,00
2021-08-03 2021-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2.875 2.875 -50,00
2021-08-03 2021-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -3.743 182.367 -2,01 27,33 -102.296 4.984.090
2021-08-03 2021-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 9.020 186.110 5,09
2021-06-04 2021-06-02 4 ANNX Annexon, Inc.
Stock Option (Right to Buy)
A - Award 10.000 10.000
2021-03-03 2021-03-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 22.102 22.102
2021-03-03 2021-03-01 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 38.739 38.739
2021-03-03 2021-02-28 4 GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 140 177.090 0,08 36,21 5.069 6.412.429
2021-02-03 2021-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3.020 18.120 -14,29
2021-02-03 2021-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3.125 12.500 -20,00
2021-02-03 2021-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2.875 5.750 -33,33
2021-02-03 2021-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -4.063 0 -100,00
2021-02-03 2021-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -4.646 176.950 -2,56 49,49 -229.931 8.757.256
2021-02-03 2021-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 13.083 181.596 7,76
2020-08-04 2020-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3.020 21.140 -12,50
2020-08-04 2020-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3.125 15.625 -16,67
2020-08-04 2020-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2.875 8.625 -25,00
2020-08-04 2020-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -4.062 4.063 -49,99
2020-08-04 2020-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -6.239 168.513 -3,57 67,48 -421.008 11.371.257
2020-08-04 2020-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 13.082 174.752 8,09
2020-08-04 2020-07-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 162 161.670 0,10 36,68 5.942 5.930.056
2020-06-03 2020-06-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 42.400 42.400
2020-02-04 2020-02-03 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 38.500 38.500
2020-02-04 2020-02-03 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 24.160 24.160
2020-02-04 2020-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3.125 18.750 -14,29
2020-02-04 2020-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2.875 11.500 -20,00
2020-02-04 2020-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -4.063 8.125 -33,34
2020-02-04 2020-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -3.570 161.508 -2,16 65,26 -232.978 10.540.012
2020-02-04 2020-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 10.063 165.078 6,49
2020-02-04 2020-01-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 286 155.015 0,18 36,68 10.490 5.685.950
2019-12-17 2019-12-13 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -5.000 0 -100,00
2019-12-17 2019-12-13 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -2.479 154.729 -1,58 76,88 -190.586 11.895.566
2019-12-17 2019-12-13 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 5.000 157.208 3,28
2019-08-05 2019-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3.125 21.875 -12,50
2019-08-05 2019-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2.875 14.375 -16,67
2019-08-05 2019-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -4.062 12.188 -25,00
2019-08-05 2019-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -3.990 152.208 -2,55 54,25 -216.458 8.257.284
2019-08-05 2019-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 10.062 156.198 6,89
2019-08-05 2019-07-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 285 146.136 0,20 36,68 10.454 5.360.268
2019-04-10 2019-04-08 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2.000 5.000 -28,57
2019-04-10 2019-04-08 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -692 145.851 -0,47 58,51 -40.489 8.533.742
2019-04-10 2019-04-08 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2.000 146.543 1,38
2019-04-10 2019-01-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 269 144.543 0,19 36,68 9.867 5.301.837
2019-02-14 2018-07-31 5 GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 277 144.274 0,19 35,53 9.842 5.126.055
2019-02-05 2019-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2.875 17.250 -14,29
2019-02-05 2019-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -4.063 16.250 -20,00
2019-02-05 2019-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 25.000 25.000
2019-02-05 2019-02-01 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 40.000 40.000
2019-02-05 2019-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -2.515 143.997 -1,72 48,44 -121.827 6.975.215
2019-02-05 2019-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 6.938 146.512 4,97
2018-08-03 2018-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2.875 20.125 -12,50
2018-08-03 2018-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -4.062 20.313 -16,66
2018-08-03 2018-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -3.440 139.574 -2,41 43,15 -148.436 6.022.618
2018-08-03 2018-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 6.937 143.014 5,10
2018-05-21 2018-05-17 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -601 2.675 -18,35
2018-05-21 2018-05-17 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -601 2.675 -18,35
2018-05-21 2018-05-17 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -198 74.964 -0,26
2018-05-21 2018-05-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1.400 136.077 -1,02 48,25 -67.550 6.565.715
2018-05-21 2018-05-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 137.477 0,44 3,40 2.043 467.422
2018-05-21 2018-05-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 137.477 0,44 3,40 2.043 467.422
2018-05-21 2018-05-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 198 136.275 0,15 3,40 673 463.335
2018-05-21 2018-05-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1.600 136.077 -1,16 48,25 -77.200 6.565.715
2018-04-19 2018-04-17 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -601 3.276 -15,50
2018-04-19 2018-04-17 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -601 3.276 -15,50
2018-04-19 2018-04-17 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -198 75.162 -0,26
2018-04-19 2018-04-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1.400 137.677 -1,01 45,50 -63.700 6.264.304
2018-04-19 2018-04-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 139.077 0,43 3,40 2.043 472.862
2018-04-19 2018-04-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 139.077 0,43 3,40 2.043 472.862
2018-04-19 2018-04-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 198 137.875 0,14 3,40 673 468.775
2018-04-19 2018-04-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1.600 137.677 -1,15 45,50 -72.800 6.264.304
2018-03-20 2018-03-16 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -601 3.877 -13,42
2018-03-20 2018-03-16 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -601 3.877 -13,42
2018-03-20 2018-03-16 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -198 75.360 -0,26
2018-03-20 2018-03-16 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1.400 139.277 -1,00 54,15 -75.810 7.541.850
2018-03-20 2018-03-16 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 140.677 0,43 3,40 2.043 478.302
2018-03-20 2018-03-16 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 140.677 0,43 3,40 2.043 478.302
2018-03-20 2018-03-16 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 198 139.475 0,14 3,40 673 474.215
2018-03-20 2018-03-16 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1.600 139.277 -1,14 54,15 -86.640 7.541.850
2018-02-21 2018-02-16 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -601 4.478 -11,83
2018-02-21 2018-02-16 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -601 4.478 -11,83
2018-02-21 2018-02-16 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -198 75.558 -0,26
2018-02-21 2018-02-16 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1.400 140.877 -0,98 62,95 -88.130 8.868.207
2018-02-21 2018-02-16 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 142.277 0,42 3,40 2.043 483.742
2018-02-21 2018-02-16 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 142.277 0,42 3,40 2.043 483.742
2018-02-21 2018-02-16 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 198 141.075 0,14 3,40 673 479.655
2018-02-21 2018-02-16 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1.600 140.877 -1,12 62,95 -100.720 8.868.207
2018-02-16 2018-02-14 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2.000 7.000 -22,22
2018-02-16 2018-02-14 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -692 142.477 -0,48 62,30 -43.112 8.876.317
2018-02-16 2018-02-14 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2.000 143.169 1,42
2018-02-14 2017-07-31 5 GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 676 135.931 0,50 13,69 9.254 1.860.895
2018-02-02 2018-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 23.000 23.000
2018-02-02 2018-02-01 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 35.000 35.000
2018-02-02 2018-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -4.063 24.375 -14,29
2018-02-02 2018-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -1.405 140.058 -0,99 59,60 -83.738 8.347.457
2018-02-02 2018-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 4.063 141.463 2,96
2018-02-02 2018-01-31 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2.000 9.000 -18,18
2018-02-02 2018-01-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -692 137.400 -0,50 57,90 -40.067 7.955.460
2018-02-02 2018-01-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2.000 138.092 1,47
2018-01-26 2018-01-24 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2.000 11.000 -15,38
2018-01-26 2018-01-24 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -686 136.092 -0,50 58,15 -39.891 7.913.750
2018-01-26 2018-01-24 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2.000 136.778 1,48
2018-01-18 2018-01-17 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (Right to Buy)
M - Exercise -601 5.079 -10,58
2018-01-18 2018-01-17 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (Right to Buy)
M - Exercise -601 5.079 -10,58
2018-01-18 2018-01-17 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (Right to Buy)
M - Exercise -198 75.756 -0,26
2018-01-18 2018-01-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1.600 134.778 -1,17 52,85 -84.560 7.123.017
2018-01-18 2018-01-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1.400 136.378 -1,02 52,85 -73.990 7.207.577
2018-01-18 2018-01-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 137.778 0,44 3,40 2.043 468.445
2018-01-18 2018-01-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 137.778 0,44 3,40 2.043 468.445
2018-01-18 2018-01-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 198 136.576 0,15 3,40 673 464.358
2018-01-18 2018-01-16 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2.000 13.000 -13,33
2018-01-18 2018-01-16 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -877 136.378 -0,64 52,10 -45.692 7.105.294
2018-01-18 2018-01-16 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2.000 137.255 1,48
2017-12-20 2017-12-18 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -601 5.680 -9,57
2017-12-20 2017-12-18 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -601 5.680 -9,57
2017-12-20 2017-12-18 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -198 75.954 -0,26
2017-12-20 2017-12-18 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1.400 135.255 -1,02 36,55 -51.170 4.943.570
2017-12-20 2017-12-18 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 136.655 0,44 3,40 2.043 464.627
2017-12-20 2017-12-18 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 136.655 0,44 3,40 2.043 464.627
2017-12-20 2017-12-18 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 198 135.453 0,15 3,40 673 460.540
2017-12-20 2017-12-18 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1.600 135.255 -1,17 36,55 -58.480 4.943.570
2017-11-21 2017-11-17 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -601 6.281 -8,73
2017-11-21 2017-11-17 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -601 6.281 -8,73
2017-11-21 2017-11-17 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -198 76.152 -0,26
2017-11-21 2017-11-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1.400 136.855 -1,01 39,75 -55.650 5.439.986
2017-11-21 2017-11-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 138.255 0,44 3,40 2.043 470.067
2017-11-21 2017-11-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 138.255 0,44 3,40 2.043 470.067
2017-11-21 2017-11-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 198 137.053 0,14 3,40 673 465.980
2017-11-21 2017-11-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1.600 136.855 -1,16 39,75 -63.600 5.439.986
2017-10-18 2017-10-17 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -601 6.882 -8,03
2017-10-18 2017-10-17 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -601 6.882 -8,03
2017-10-18 2017-10-17 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -198 76.350 -0,26
2017-10-18 2017-10-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1.400 138.455 -1,00 32,65 -45.710 4.520.556
2017-10-18 2017-10-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 139.855 0,43 3,40 2.043 475.507
2017-10-18 2017-10-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 139.855 0,43 3,40 2.043 475.507
2017-10-18 2017-10-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 198 138.653 0,14 3,40 673 471.420
2017-10-18 2017-10-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1.600 138.455 -1,14 32,65 -52.240 4.520.556
2017-10-02 2017-09-29 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -601 7.483 -7,43
2017-10-02 2017-09-29 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -601 7.483 -7,43
2017-10-02 2017-09-29 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -198 76.548 -0,26
2017-10-02 2017-09-29 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1.400 140.055 -0,99 30,00 -42.000 4.201.650
2017-10-02 2017-09-29 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 141.455 0,43 3,40 2.043 480.947
2017-10-02 2017-09-29 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 141.455 0,43 3,40 2.043 480.947
2017-10-02 2017-09-29 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 198 140.253 0,14 3,40 673 476.860
2017-10-02 2017-09-29 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1.600 140.055 -1,13 30,00 -48.000 4.201.650
2017-09-05 2017-08-31 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -601 8.084 -6,92
2017-09-05 2017-08-31 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -601 8.084 -6,92
2017-09-05 2017-08-31 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -198 76.746 -0,26
2017-09-05 2017-08-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1.400 141.655 -0,98 30,00 -42.000 4.249.650
2017-09-05 2017-08-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 143.055 0,42 3,40 2.043 486.387
2017-09-05 2017-08-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 143.055 0,42 3,40 2.043 486.387
2017-09-05 2017-08-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 198 141.853 0,14 3,40 673 482.300
2017-09-05 2017-08-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1.600 141.655 -1,12 30,00 -48.000 4.249.650
2017-08-14 2017-08-11 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 15.000 15.000
2017-08-03 2017-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -4.062 28.438 -12,50
2017-08-03 2017-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -1.527 145.790 -1,04 25,10 -38.328 3.659.329
2017-08-03 2017-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 4.062 147.317 2,84
2017-07-25 2017-07-21 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -601 8.685 -6,47
2017-07-25 2017-07-21 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -601 8.685 -6,47
2017-07-25 2017-07-21 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -198 76.944 -0,26
2017-07-25 2017-07-21 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1.400 143.255 -0,97 30,00 -42.000 4.297.650
2017-07-25 2017-07-21 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 144.655 0,42 3,40 2.043 491.827
2017-07-25 2017-07-21 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 144.655 0,42 3,40 2.043 491.827
2017-07-25 2017-07-21 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 198 143.453 0,14 3,40 673 487.740
2017-07-25 2017-07-21 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1.600 143.255 -1,10 30,00 -48.000 4.297.650
2017-02-14 2017-01-31 5 GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 658 144.855 0,46 13,73 9.034 1.988.859
2017-02-14 2016-07-31 5 GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 591 144.197 0,41 15,20 8.983 2.191.794
2017-01-19 2017-01-17 4 GBT Global Blood Therapeutics, Inc.
Stock Option (right to buy)
A - Award 49.000 49.000
2017-01-19 2017-01-17 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 32.500 32.500
2016-10-03 2016-09-29 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 9.286 9.286
2016-03-14 2016-03-10 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 9.286 9.286
2016-03-14 2016-02-01 4/A GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 749 143.606 0,52 16,09 12.051 2.310.621
2016-03-14 2015-08-17 4/A GBT Global Blood Therapeutics, Inc.
Common Stock
P - Purchase 25.000 25.000 20,00 500.000 500.000
2016-02-03 2016-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 749 168.606 0,45 16,09 12.051 2.712.871
2016-01-07 2015-08-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
P - Purchase 25.000 167.857 17,50 20,00 500.000 3.357.140
2015-08-11 3 GBT Global Blood Therapeutics, Inc.
Common Stock
285.714
2015-08-11 3 GBT Global Blood Therapeutics, Inc.
Common Stock
285.714
P
Acquisto sul mercato aperto o privato di un titolo non derivato o derivato
S
Vendita sul mercato aperto o privato di un titolo non derivato o derivato
A
Concessione, assegnazione o altra acquisizione di titoli dall'azienda (ad esempio un'opzione)
C
Conversione di un derivato
D
Vendita o trasferimento di titoli alla società
F
Pagamento del prezzo di esercizio o del debito fiscale con la quota di titoli ricevuta dalla società
G
Regalo di titoli da parte o a favore dell'insider
K
Equity swap e operazioni di copertura analoghe
M
Esercizio o conversione di un titolo derivato ricevuto dall'azienda (ad esempio un'opzione)
V
Una transazione dichiarata volontariamente sul modulo 4
J
Altro (accompagnato da una nota a piè di pagina che descriva l'operazione)